These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30866658)

  • 1. Is Homoarginine a Protective Cardiovascular Risk Factor?
    Karetnikova ES; Jarzebska N; Markov AG; Weiss N; Lentz SR; Rodionov RN
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):869-875. PubMed ID: 30866658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Pathway for Metabolism of the Cardiovascular Risk Factor Homoarginine by alanine:glyoxylate aminotransferase 2.
    Rodionov RN; Oppici E; Martens-Lobenhoffer J; Jarzebska N; Brilloff S; Burdin D; Demyanov A; Kolouschek A; Leiper J; Maas R; Cellini B; Weiss N; Bode-Böger SM
    Sci Rep; 2016 Oct; 6():35277. PubMed ID: 27752063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homoarginine and cardiovascular outcome in the population-based Dallas Heart Study.
    Atzler D; Gore MO; Ayers CR; Choe CU; Böger RH; de Lemos JA; McGuire DK; Schwedhelm E
    Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2501-7. PubMed ID: 25189571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-homoarginine and cardiovascular disease.
    Atzler D; Schwedhelm E; Choe CU
    Curr Opin Clin Nutr Metab Care; 2015 Jan; 18(1):83-8. PubMed ID: 25474016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobacco smoking decreases plasma concentration of the emerging cardiovascular risk marker, L-homoarginine.
    Sobczak A; Prokopowicz A; Radek M; Szula M; Zaciera M; Kurek J; Goniewicz ML
    Circ J; 2014; 78(5):1254-8. PubMed ID: 24583919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homoarginine in the cardiovascular system: Pathophysiology and recent developments.
    Koch V; Gruenewald LD; Gruber-Rouh T; Eichler K; Leistner DM; Mahmoudi S; Booz C; Bernatz S; D'Angelo T; Albrecht MH; Alizadeh LS; Nour-Eldin NA; Scholtz JE; Yel I; Vogl TJ; März W; Hardt SE; Martin SS
    Fundam Clin Pharmacol; 2023 Jun; 37(3):519-529. PubMed ID: 36509694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-homoarginine is associated with decreased cardiovascular- and all-cause mortality.
    Mokhaneli MC; Botha-Le Roux S; Fourie CMT; Böger R; Schwedhelm E; Mels CMC
    Eur J Clin Invest; 2021 May; 51(5):e13472. PubMed ID: 33320332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of methylarginines and homoarginine with diastolic dysfunction and cardiovascular risk factors in patients with preserved left ventricular ejection fraction.
    Pilz S; Edelmann F; Meinitzer A; Gelbrich G; Döner U; Düngen HD; Tomaschitz A; Kienreich K; Gaksch M; Duvinage A; Stahrenberg R; Kunde J; Schmidt A; März W; Wachter R; Pieske B
    J Card Fail; 2014 Dec; 20(12):923-30. PubMed ID: 25230239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study.
    Drechsler C; Pihlstrøm H; Meinitzer A; Pilz S; Tomaschitz A; Abedini S; Fellstrom B; Jardine AG; Wanner C; März W; Holdaas H
    Transplantation; 2015 Jul; 99(7):1470-6. PubMed ID: 25675199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease.
    Hov GG; Aasarød KI; Sagen E; Åsberg A
    Clin Biochem; 2015 Jul; 48(10-11):646-51. PubMed ID: 25828044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homoarginine in the renal and cardiovascular systems.
    Pilz S; Meinitzer A; Gaksch M; Grübler M; Verheyen N; Drechsler C; Hartaigh BÓ; Lang F; Alesutan I; Voelkl J; März W; Tomaschitz A
    Amino Acids; 2015 Sep; 47(9):1703-13. PubMed ID: 25929587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reference intervals of plasma homoarginine from the German Gutenberg Health Study.
    Atzler D; Appelbaum S; Cordts K; Ojeda FM; Wild PS; Münzel T; Blankenberg S; Böger RH; Blettner M; Beutel ME; Pfeiffer N; Zeller T; Lackner KJ; Schwedhelm E
    Clin Chem Lab Med; 2016 Jul; 54(7):1231-7. PubMed ID: 26562034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homoarginine, cardiovascular risk, and mortality.
    März W; Meinitzer A; Drechsler C; Pilz S; Krane V; Kleber ME; Fischer J; Winkelmann BR; Böhm BO; Ritz E; Wanner C
    Circulation; 2010 Sep; 122(10):967-75. PubMed ID: 20733103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homoarginine/ADMA ratio and homoarginine/SDMA ratio as independent predictors of cardiovascular mortality and cardiovascular events in lower extremity arterial disease.
    Jud P; Hafner F; Verheyen N; Meinitzer A; Gary T; Brodmann M; Seinost G; Hackl G
    Sci Rep; 2018 Sep; 8(1):14197. PubMed ID: 30242192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homoarginine and all-cause mortality: A systematic review and meta-analysis.
    Zinellu A; Paliogiannis P; Carru C; Mangoni AA
    Eur J Clin Invest; 2018 Aug; 48(8):e12960. PubMed ID: 29806958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promiscuous activity of arginine:glycine amidinotransferase is responsible for the synthesis of the novel cardiovascular risk factor homoarginine.
    Davids M; Ndika JD; Salomons GS; Blom HJ; Teerlink T
    FEBS Lett; 2012 Oct; 586(20):3653-7. PubMed ID: 23010440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association study identifies 3 genomic loci significantly associated with serum levels of homoarginine: the AtheroRemo Consortium.
    Kleber ME; Seppälä I; Pilz S; Hoffmann MM; Tomaschitz A; Oksala N; Raitoharju E; Lyytikäinen LP; Mäkelä KM; Laaksonen R; Kähönen M; Raitakari OT; Huang J; Kienreich K; Fahrleitner-Pammer A; Drechsler C; Krane V; Boehm BO; Koenig W; Wanner C; Lehtimäki T; März W; Meinitzer A
    Circ Cardiovasc Genet; 2013 Oct; 6(5):505-13. PubMed ID: 24047826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homoarginine levels are regulated by L-arginine:glycine amidinotransferase and affect stroke outcome: results from human and murine studies.
    Choe CU; Atzler D; Wild PS; Carter AM; Böger RH; Ojeda F; Simova O; Stockebrand M; Lackner K; Nabuurs C; Marescau B; Streichert T; Müller C; Lüneburg N; De Deyn PP; Benndorf RA; Baldus S; Gerloff C; Blankenberg S; Heerschap A; Grant PJ; Magnus T; Zeller T; Isbrandt D; Schwedhelm E
    Circulation; 2013 Sep; 128(13):1451-61. PubMed ID: 24004504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homoarginine, kidney function and cardiovascular mortality risk.
    Tomaschitz A; Meinitzer A; Pilz S; Rus-Machan J; Genser B; Drechsler C; Grammer T; Krane V; Ritz E; Kleber ME; Pieske B; Kraigher-Krainer E; Fahrleitner-Pammer A; Wanner C; Boehm BO; März W
    Nephrol Dial Transplant; 2014 Mar; 29(3):663-71. PubMed ID: 24398889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells.
    Davids M; Teerlink T
    Metabolism; 2013 Oct; 62(10):1455-61. PubMed ID: 23890667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.